KBI Biopharma is headed to Lausanne, Switzerland for the A3P Switzerland Forum this September!
Schedule a meeting >>
About KBI Biopharma:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
This forum will address the lifecycle of analytical methods based on practical experiences following the publication of regulatory texts USP <1220>, ICHQ2R2/ICHQ14, with a focus on integrating rapid microbiology methods and digitalization. It will highlight the transformative potential of digitalization and the evolution in methods selection, promoting agility, efficiency and robustness in methods transfer and drugs testing.